DG
JNJ icon

Delek Group’s Johnson & Johnson JNJ Stock Holding History

Delek Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,705
Closed -$3.21M – 242
2018
Q2 		$3.21M Sell
22,705
-6,855
-23% -$855K 0.14% 148
2018
Q1 		$4.1M Buy
29,560
+1,920
+7% +$260K 0.21% 124
2017
Q4 		$3.9M Buy
+27,640
New +$3.85M 0.21% 126

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Delek Group's JNJ Position: Q3 2018 in Review

Delek Group sold out of Johnson & Johnson (JNJ) in Q3 2018, closing a stake of 22,705 shares — an estimated $3.21M sold.

Delek Group first reported a position in JNJ in Q4 2017 and held it in 3 quarters. The position peaked at $4.1M in Q1 2018. 2,584 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.

  • Delek Group reported no remaining Johnson & Johnson position as of Q3 2018 after selling out during the quarter.
  • Delek Group sold 22,705 Johnson & Johnson shares in Q3 2018, an estimated $3.21M.
  • Delek Group first reported a position in Johnson & Johnson in Q4 2017 and held it in 3 quarters.
  • Delek Group's Johnson & Johnson position peaked at $4.1M in Q1 2018.
  • 2,584 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.

Based on Delek Group's 13F filing for Q3 2018, filed 14 Nov 2018.